The India Preclinical Research Market size was valued at around USD 175 million in 2024 and is projected to reach USD 300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.5% during the forecast period (2025-30).
India Preclinical Research Market Driver:
Regulatory Support & Policy Initiatives by the Government Augmenting Market Demand – Due to the rise in diseases in India, there is a high expenditure on preclinical research and development of drugs. It is supported by various policies and government initiatives like the Make in India, Production-Linked Incentive (PLI) Scheme, Promotion of Medical Devices Parks Scheme, etc. PLI scheme provides incentives up to USD 456 million. It is to boost the domestic research, investments, and manufacturing of medical devices such as cancer care devices, radiology and imaging devices, anesthetics devices, implants, etc. This drives the market towards growth by bringing multiple global investments into the market. Also, the Central Drugs Standard Control Organization has implemented various measures like faster timelines for approval, and an online system for submission & monitoring, to streamline the process from preclinical to clinical phases. India is aligning its regulatory framework with international guidelines like Good Laboratory Practice & Good Clinical Practice which is important to ensure data credibility in preclinical research encouraging global acceptance and investment in the Indian market. For Instance;
- In 2022, India attracted 225 R&D projects valued up to USD 12.9 billion in capital expenditure.
Moreover, the budget allocations from the government help to strengthen the infrastructure required for preclinical research. As per the 2024 Union budget, the allocation of funds towards biotechnology R&D was around USD 130.37 million involving preclinical research and other processes. Furthermore, with collaborations with International Regulatory Bodies, India signed agreements with several countries allowing companies to facilitate mutual recognition of data and allowing Indian researched drugs to enter the global market. These agreements allow companies to justify the use of Indian facilities for preclinical trials ultimately driving the market towards exponential growth.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/india-pre-clinical-research-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/india-pre-clinical-research-market.html
India Preclinical Research Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2024
-Historical Period: 2020 to 2023
-Forecast Period: 2025 to 2030
- By Model Type
- Patient-Derived Organoid (PDO) model- Market Size & Forecast 2020-2030, USD Million
- Patient-Derived Xenograft (PDX) model- Market Size & Forecast 2020-2030, USD Million
- By Service
- Bioanalysis and DMPK studies- Market Size & Forecast 2020-2030, USD Million
- In vitro ADME- Market Size & Forecast 2020-2030, USD Million
- In-vivo PK- Market Size & Forecast 2020-2030, USD Million
- Toxicology testing- Market Size & Forecast 2020-2030, USD Million
- GLP- Market Size & Forecast 2020-2030, USD Million
- Non-GLP- Market Size & Forecast 2020-2030, USD Million
- Compound management- Market Size & Forecast 2020-2030, USD Million
- Process R&D- Market Size & Forecast 2020-2030, USD Million
- Custom synthesis- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Chemistry- Market Size & Forecast 2020-2030, USD Million
- Medicinal chemistry- Market Size & Forecast 2020-2030, USD Million
- Computation chemistry- Market Size & Forecast 2020-2030, USD Million
- Safety Pharmacology-Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Bioanalysis and DMPK studies- Market Size & Forecast 2020-2030, USD Million
- By End User
- Biopharmaceutical Companies- Market Size & Forecast 2020-2030, USD Million
- Government and academic institutes- Market Size & Forecast 2020-2030, USD Million
- Medical device companies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- By Region
- North
- East
- West
- South
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Syngene International Limited, Dabur Research, JSS Medical Research, Jubilant Biosys Ltd., Sugen Life Sciences, Eurofins Advinus, GVRP, Veeda Clinical Research Limited, Axis Clinicals, Syneos Health, Ethicare-cro, Liveon Biolabs Pvt. Ltd., IQVIA Inc., Bioneeds, TheraIndx Lifesciences Pvt. Ltd., Abiogenesis Clinpharm, Accutest Global, Asiatic Clinical Research, Bio Reliance Corporation, Cliniminds, Hi Tech Bio Laboratories, GVK Biosciences, and others
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/india-pre-clinical-research-market.html
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
